SGHT

Sight Sciences, Inc.

Investor Moves

NameValueActionChangePriceLast Price
Ken GriffinCitadel Advisors
$510k135.3k shares
TrimQ1 2026
$662k
$3.77
$5.06
Steven CohenPoint72
$372k98.7k shares
AddQ1 2026
$32k
$3.77
$5.06
Jim SimonsRenaissance Technologies
$1M293.4k shares
TrimQ1 2026
$1M
$3.77
$5.06
Jefferies GroupInvestor
$-325.1K
ExitQ1 2026
$325k
--
$5.06
Jim SimonsRenaissance Technologies
$895.1K
AddQ4 2025
$895k
--
$5.06
Ken GriffinCitadel Advisors
$-391.8K
ExitQ3 2025
$392k
--
$5.06

Insider Trades

NameValueActionPriceLast Price
Bauerlein AlisonChief Operating Officer
$65k12.7k shares
SellMay 18, 2026
$5.12
$5.06
Hayden Jeremy B.Chief Legal Officer
$49k13.8k shares
SellApr 6, 2026
$3.55
$5.06
Rodberg JamesChief Financial Officer
$26k7.2k shares
SellApr 6, 2026
$3.55
$5.06
Badawi PaulDirector, 10 Percent Owner, Officer: President And CEO
$108k29.2k shares
SellApr 1, 2026
$3.70
$5.06
Bauerlein AlisonChief Operating Officer
$90k25.9k shares
SellApr 2, 2026
$3.48
$5.06
Badawi DavidDirector, Officer: Chief Technology Officer
$28k8.2k shares
SellApr 2, 2026
$3.48
$5.06

News

seekingalpha.comSight Sciences, Inc. (SGHT) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcriptseekingalpha.comMay 13seekingalpha.comSight Sciences, Inc. (SGHT) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 7zacks.comSight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimateszacks.comMay 6zacks.comSight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimateszacks.comMay 6globenewswire.comSight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidanceglobenewswire.comMay 6